Peptide record

TPDB05762

Antibacterial Anticancer Antifungal Hemolysis Toxicity standard
9 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.
TPDB05762
Antibacterial Anticancer Antifungal Hemolysis Toxicity
Anti-infective peptides Cancer-related peptides Toxicity and safety peptides
AntiBP3 Peptipedia CAFPdb dbAMP HemoPI Hemolytic2 PD_Hemolysis
standard
No
A 9-aa standard-residue multi-activity (Antibacterial, Anticancer, Antifungal, and other sources) peptide sequence curated from AntiBP3, Peptipedia, CAFPdb, and other sources, with an available 3D structural model.
Sequence
KWRRWIRWL
Physicochemical Analysis

Sequence-only estimates for a linear peptide with free termini, not experimentally measured molecular properties. Mass and formula exclude cyclization and disulfide formation. The optical estimates assume paired cysteines, 280 nm, 1 g/L and a 1 cm path. The N-end rule estimate is not a measured plasma half-life.

C69H102N22O10
ANDCEQGHMFPSTYV
RW
1399.71
12.71
4
0
5
+4
3.72
-1.311
86.67
Mammalian: 1.3 hour Yeast: 3 min E.coli: 2 min
16500
11.79
0
Residue Composition
number
0
A
3
R
0
N
0
D
0
C
0
E
0
Q
0
G
0
H
1
I
1
L
1
K
0
M
0
F
0
P
0
S
0
T
3
W
0
Y
0
V
Amino Acid Distribution
A: 0 R: 3 N: 0 D: 0 C: 0 E: 0 Q: 0 G: 0 H: 0 I: 1 L: 1 K: 1 M: 0 F: 0 P: 0 S: 0 T: 0 W: 3 Y: 0 V: 0
Chemical Descriptors
9 reviewed residue count
C69H102N22O10 sequence-only estimate (linear, free termini)
1399.71 sequence-only estimate (linear, free termini)
12.71 sequence-only estimate (linear, free termini)
+4 sequence-only estimate (linear, free termini)
3.72 sequence-only estimate (linear, free termini)
-1.311 sequence-only estimate (linear, free termini)
Evidence Records 14 records
Evidence 1 Activity

Activity

MIC
Antibacterial
6.2 µg/mL

Target

Escherichia coli

Source & Reference

dbAMP

Other

Source Activity Label Source Definition
Antibacterial
dbAMP classified as Antibacterial under the Anti-bacterial function class.
active against Gram- E. coli (MIC 6.2 ug/ml), P. aeruginosa (MIC 6.2 ug/ml), Gram+ S. aeurus (MIC 3.1 ug/ml), fungi C. albicans (MIC 3
Evidence 2 Activity

Activity

MIC
Antibacterial
6.2 µg/mL

Target

Pseudomonas aeruginosa

Source & Reference

dbAMP

Other

active against Gram- E. coli (MIC 6.2 ug/ml), P. aeruginosa (MIC 6.2 ug/ml), Gram+ S. aeurus (MIC 3.1 ug/ml), fungi C. albicans (MIC 3.1 ug/ml), and F. solani (MIC 2
Evidence 3 Activity

Activity

MIC
Antibacterial
3.1 µg/mL

Target

S. aeurus

Source & Reference

dbAMP

Other

active against Gram- E. coli (MIC 6.2 ug/ml), P. aeruginosa (MIC 6.2 ug/ml), Gram+ S. aeurus (MIC 3.1 ug/ml), fungi C. albicans (MIC 3.1 ug/ml), and F. solani (MIC 25 ug/ml).
Evidence 4 Activity

Activity

MIC
Antibacterial
3.1 µg/mL

Target

Candida albicans

Source & Reference

dbAMP

Other

li (MIC 6.2 ug/ml), P. aeruginosa (MIC 6.2 ug/ml), Gram+ S. aeurus (MIC 3.1 ug/ml), fungi C. albicans (MIC 3.1 ug/ml), and F. solani (MIC 25 ug/ml).
Evidence 5 Activity

Activity

MIC
Antibacterial
25 µg/mL

Target

F. solani

Source & Reference

dbAMP

Other

(MIC 6.2 ug/ml), Gram+ S. aeurus (MIC 3.1 ug/ml), fungi C. albicans (MIC 3.1 ug/ml), and F. solani (MIC 25 ug/ml).
Evidence 6 Activity

Activity

MIC
Antifungal
6.2 µg/mL

Target

Escherichia coli

Source & Reference

dbAMP CAFPdb

Other

Source Activity Label Source Definition
Antifungal
dbAMP classified under the Anti-fungal function class.
active against Gram- E. coli (MIC 6.2 ug/ml), P. aeruginosa (MIC 6.2 ug/ml), Gram+ S. aeurus (MIC 3.1 ug/ml), fungi C. albicans (MIC 3
Evidence 7 Activity

Activity

MIC
Antifungal
6.2 µg/mL

Target

Pseudomonas aeruginosa

Source & Reference

dbAMP CAFPdb

Other

active against Gram- E. coli (MIC 6.2 ug/ml), P. aeruginosa (MIC 6.2 ug/ml), Gram+ S. aeurus (MIC 3.1 ug/ml), fungi C. albicans (MIC 3.1 ug/ml), and F. solani (MIC 2
Evidence 8 Activity

Activity

MIC
Antifungal
3.1 µg/mL

Target

S. aeurus

Source & Reference

dbAMP CAFPdb

Other

active against Gram- E. coli (MIC 6.2 ug/ml), P. aeruginosa (MIC 6.2 ug/ml), Gram+ S. aeurus (MIC 3.1 ug/ml), fungi C. albicans (MIC 3.1 ug/ml), and F. solani (MIC 25 ug/ml).
Evidence 9 Activity

Activity

MIC
Antifungal
3.1 µg/mL

Target

Candida albicans

Source & Reference

dbAMP CAFPdb

Other

li (MIC 6.2 ug/ml), P. aeruginosa (MIC 6.2 ug/ml), Gram+ S. aeurus (MIC 3.1 ug/ml), fungi C. albicans (MIC 3.1 ug/ml), and F. solani (MIC 25 ug/ml).
Evidence 10 Activity

Activity

MIC
Antifungal
25 µg/mL

Target

F. solani

Source & Reference

dbAMP CAFPdb

Other

(MIC 6.2 ug/ml), Gram+ S. aeurus (MIC 3.1 ug/ml), fungi C. albicans (MIC 3.1 ug/ml), and F. solani (MIC 25 ug/ml).
Evidence 11 Activity

Activity

50% Hemolysis
Toxicity
400 µg/mL
Hemolytic Cytotoxic
50% Hemolysis | 400 | µg/mL | target cell: Human erythrocytes

Target

Human erythrocytes

Source & Reference

NA
DBAASP
Novel short antibacterial and antifungal peptides with low cytotoxicity: Efficacy and action mechanisms. | Biochem Biophys Res Commun | 2010
Evidence 12 Activity

Activity

IC50
Toxicity
43±16 µM
Cytotoxic
IC50 | 43±16 | µM | target cell: Mouse fibroblasts NIH 3T3

Target

Mouse fibroblasts NIH 3T3

Source & Reference

NA
DBAASP
Repurposing azithromycin and rifampicin against Gram-negative pathogens by combination with peptide potentiators. | Int J Antimicrob Agents | 2019
Evidence 13 Activity

Activity

Toxicity
Hemolytic Cytotoxic
Hemolytic_activity: Not available | Cytotoxicity: Not available

Target

erythrocytes

Source & Reference

NA
DRAMP
Int J Antimicrob Agents. 2019 Jun 53(6):868-872.
Evidence 14 Hemolysis

Source & Reference

HemoPI PD_Hemolysis
PD_Hemolysis